UniProt ID | ESR1_HUMAN | |
---|---|---|
UniProt AC | P03372 | |
Protein Name | Estrogen receptor | |
Gene Name | ESR1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 595 | |
Subcellular Localization |
Isoform 1: Nucleus . Cytoplasm . Cell membrane Peripheral membrane protein Cytoplasmic side . A minor fraction is associated with the inner membrane. Isoform 3: Nucleus. Cytoplasm. Cell membrane Peripheral membrane protein Cytoplasmic side. Ce |
|
Protein Description | Nuclear hormone receptor. The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Ligand-dependent nuclear transactivation involves either direct homodimer binding to a palindromic estrogen response element (ERE) sequence or association with other DNA-binding transcription factors, such as AP-1/c-Jun, c-Fos, ATF-2, Sp1 and Sp3, to mediate ERE-independent signaling. Ligand binding induces a conformational change allowing subsequent or combinatorial association with multiprotein coactivator complexes through LXXLL motifs of their respective components. Mutual transrepression occurs between the estrogen receptor (ER) and NF-kappa-B in a cell-type specific manner. Decreases NF-kappa-B DNA-binding activity and inhibits NF-kappa-B-mediated transcription from the IL6 promoter and displace RELA/p65 and associated coregulators from the promoter. Recruited to the NF-kappa-B response element of the CCL2 and IL8 promoters and can displace CREBBP. Present with NF-kappa-B components RELA/p65 and NFKB1/p50 on ERE sequences. Can also act synergistically with NF-kappa-B to activate transcription involving respective recruitment adjacent response elements; the function involves CREBBP. Can activate the transcriptional activity of TFF1. Also mediates membrane-initiated estrogen signaling involving various kinase cascades. Isoform 3 is involved in activation of NOS3 and endothelial nitric oxide production. Isoforms lacking one or several functional domains are thought to modulate transcriptional activity by competitive ligand or DNA binding and/or heterodimerization with the full-length receptor. Essential for MTA1-mediated transcriptional regulation of BRCA1 and BCAS3. Isoform 3 can bind to ERE and inhibit isoform 1.. | |
Protein Sequence | MTMTLHTKASGMALLHQIQGNELEPLNRPQLKIPLERPLGEVYLDSSKPAVYNYPEGAAYEFNAAAAANAQVYGQTGLPYGPGSEAAAFGSNGLGGFPPLNSVSPSPLMLLHPPPQLSPFLQPHGQQVPYYLENEPSGYTVREAGPPAFYRPNSDNRRQGGRERLASTNDKGSMAMESAKETRYCAVCNDYASGYHYGVWSCEGCKAFFKRSIQGHNDYMCPATNQCTIDKNRRKSCQACRLRKCYEVGMMKGGIRKDRRGGRMLKHKRQRDDGEGRGEVGSAGDMRAANLWPSPLMIKRSKKNSLALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKCKNVVPLYDLLLEMLDAHRLHAPTSRGGASVEETDQSHLATAGSTSSHSLQKYYITGEAEGFPATV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MTMTLHTKA ------CCCEEECHH | 20.90 | 18187866 | |
4 | Phosphorylation | ----MTMTLHTKASG ----CCCEEECHHHH | 13.25 | 18187866 | |
7 | Phosphorylation | -MTMTLHTKASGMAL -CCCEEECHHHHHHH | 31.27 | 18187866 | |
8 | Acetylation | MTMTLHTKASGMALL CCCEEECHHHHHHHH | 29.79 | 18984578 | |
10 | O-linked_Glycosylation | MTLHTKASGMALLHQ CEEECHHHHHHHHHH | 30.56 | UniProtKB CARBOHYD | |
10 | Phosphorylation | MTLHTKASGMALLHQ CEEECHHHHHHHHHH | 30.56 | 11226831 | |
10 | O-linked_Glycosylation | MTLHTKASGMALLHQ CEEECHHHHHHHHHH | 30.56 | 11226831 | |
32 | Acetylation | PLNRPQLKIPLERPL CCCCCCCCCCCCCCC | 36.71 | 62188851 | |
46 | Phosphorylation | LGEVYLDSSKPAVYN CCEEECCCCCCCEEC | 37.35 | 20043841 | |
47 | Phosphorylation | GEVYLDSSKPAVYNY CEEECCCCCCCEECC | 42.18 | 20043841 | |
52 | Phosphorylation | DSSKPAVYNYPEGAA CCCCCCEECCCCCCC | 15.87 | 20101225 | |
102 | Phosphorylation | GGFPPLNSVSPSPLM CCCCCCCCCCCCCEE | 31.49 | 10949034 | |
104 | Phosphorylation | FPPLNSVSPSPLMLL CCCCCCCCCCCEEEC | 21.34 | 17068199 | |
106 | Phosphorylation | PLNSVSPSPLMLLHP CCCCCCCCCEEECCC | 24.14 | 17068199 | |
118 | Phosphorylation | LHPPPQLSPFLQPHG CCCCCCCCCCCCCCC | 14.36 | 16113102 | |
154 | Phosphorylation | PAFYRPNSDNRRQGG CCCCCCCCCCCCCCH | 38.66 | 18367407 | |
167 | Phosphorylation | GGRERLASTNDKGSM CHHHCHHHCCCCCCH | 32.13 | 17068199 | |
171 | "N6,N6-dimethyllysine" | RLASTNDKGSMAMES CHHHCCCCCCHHHHH | 55.76 | - | |
171 | Acetylation | RLASTNDKGSMAMES CHHHCCCCCCHHHHH | 55.76 | 62188855 | |
171 | Methylation | RLASTNDKGSMAMES CHHHCCCCCCHHHHH | 55.76 | - | |
171 | Sumoylation | RLASTNDKGSMAMES CHHHCCCCCCHHHHH | 55.76 | - | |
180 | "N6,N6-dimethyllysine" | SMAMESAKETRYCAV CHHHHHHHHHCEEEE | 69.74 | - | |
180 | Methylation | SMAMESAKETRYCAV CHHHHHHHHHCEEEE | 69.74 | - | |
180 | Sumoylation | SMAMESAKETRYCAV CHHHHHHHHHCEEEE | 69.74 | - | |
201 | Phosphorylation | GYHYGVWSCEGCKAF CCCCEEEECCHHHHH | 10.41 | 9528769 | |
212 | Phosphorylation | CKAFFKRSIQGHNDY HHHHHHHHHCCCCCC | 21.61 | 22266331 | |
219 | Phosphorylation | SIQGHNDYMCPATNQ HHCCCCCCCCCCCCC | 13.11 | 20101225 | |
236 | Phosphorylation | IDKNRRKSCQACRLR ECCCHHHCCHHHHHH | 15.06 | 17068199 | |
244 | Acetylation | CQACRLRKCYEVGMM CHHHHHHHHHHHHCC | 45.84 | 30051005 | |
252 | Acetylation | CYEVGMMKGGIRKDR HHHHHCCCCCCCCCC | 45.13 | 30050999 | |
260 | Methylation | GGIRKDRRGGRMLKH CCCCCCCCCCCCCEE | 63.15 | 24498420 | |
260 | Asymmetric dimethylarginine | GGIRKDRRGGRMLKH CCCCCCCCCCCCCEE | 63.15 | - | |
266 | Sumoylation | RRGGRMLKHKRQRDD CCCCCCCEECCCCCC | 37.42 | - | |
266 | Sumoylation | RRGGRMLKHKRQRDD CCCCCCCEECCCCCC | 37.42 | - | |
266 | Acetylation | RRGGRMLKHKRQRDD CCCCCCCEECCCCCC | 37.42 | 20167786 | |
266 | Methylation | RRGGRMLKHKRQRDD CCCCCCCEECCCCCC | 37.42 | - | |
268 | Sumoylation | GGRMLKHKRQRDDGE CCCCCEECCCCCCCC | 48.95 | - | |
268 | Acetylation | GGRMLKHKRQRDDGE CCCCCEECCCCCCCC | 48.95 | 16497729 | |
268 | Sumoylation | GGRMLKHKRQRDDGE CCCCCEECCCCCCCC | 48.95 | - | |
277 | Dimethylation | QRDDGEGRGEVGSAG CCCCCCCCCCCCCHH | 33.52 | - | |
277 | Methylation | QRDDGEGRGEVGSAG CCCCCCCCCCCCCHH | 33.52 | - | |
282 | Phosphorylation | EGRGEVGSAGDMRAA CCCCCCCCHHHHCHH | 33.96 | 20418363 | |
294 | Phosphorylation | RAANLWPSPLMIKRS CHHHCCCCCEEEECC | 21.05 | 20418363 | |
299 | Acetylation | WPSPLMIKRSKKNSL CCCCEEEECCCCCCE | 36.33 | 11279135 | |
299 | Sumoylation | WPSPLMIKRSKKNSL CCCCEEEECCCCCCE | 36.33 | - | |
299 | Sumoylation | WPSPLMIKRSKKNSL CCCCEEEECCCCCCE | 36.33 | - | |
302 | Acetylation | PLMIKRSKKNSLALS CEEEECCCCCCEEEE | 61.07 | 11279135 | |
302 | Sumoylation | PLMIKRSKKNSLALS CEEEECCCCCCEEEE | 61.07 | - | |
302 | Methylation | PLMIKRSKKNSLALS CEEEECCCCCCEEEE | 61.07 | 18471979 | |
302 | Ubiquitination | PLMIKRSKKNSLALS CEEEECCCCCCEEEE | 61.07 | 17392432 | |
303 | Sumoylation | LMIKRSKKNSLALSL EEEECCCCCCEEEEC | 53.68 | - | |
303 | Acetylation | LMIKRSKKNSLALSL EEEECCCCCCEEEEC | 53.68 | 11279135 | |
305 | Phosphorylation | IKRSKKNSLALSLTA EECCCCCCEEEECCH | 24.73 | 17068199 | |
311 | Phosphorylation | NSLALSLTADQMVSA CCEEEECCHHHHHHH | 25.47 | 20418363 | |
328 | Phosphorylation | DAEPPILYSEYDPTR CCCCCEEEECCCCCC | 10.52 | 26074081 | |
329 | Phosphorylation | AEPPILYSEYDPTRP CCCCEEEECCCCCCC | 26.66 | 26074081 | |
341 | Phosphorylation | TRPFSEASMMGLLTN CCCCCHHHHHHHHHH | 12.78 | - | |
401 | Methylation | RSMEHPGKLLFAPNL HHCCCCCCEEECCCE | 46.60 | - | |
401 | "N6,N6-dimethyllysine" | RSMEHPGKLLFAPNL HHCCCCCCEEECCCE | 46.60 | - | |
447 | S-palmitoylation | LQGEEFVCLKSIILL CCCCCEEEEEEEHHH | 4.87 | 15033483 | |
472 | Sumoylation | TLKSLEEKDHIHRVL HHHHHHHHHHHHHHH | 45.27 | - | |
472 | Acetylation | TLKSLEEKDHIHRVL HHHHHHHHHHHHHHH | 45.27 | 18984578 | |
472 | Sumoylation | TLKSLEEKDHIHRVL HHHHHHHHHHHHHHH | 45.27 | - | |
485 | Phosphorylation | VLDKITDTLIHLMAK HHHHHHHHHHHHHHH | 20.97 | - | |
537 | Phosphorylation | CKNVVPLYDLLLEML CCCCCHHHHHHHHHH | 9.85 | 12554772 | |
537 | Dephosphorylation | CKNVVPLYDLLLEML CCCCCHHHHHHHHHH | 9.85 | 7539106 | |
554 | Phosphorylation | HRLHAPTSRGGASVE HCCCCCCCCCCCCCC | 28.06 | 18984578 | |
559 | Phosphorylation | PTSRGGASVEETDQS CCCCCCCCCCCCCHH | 33.08 | 20418363 | |
570 | Phosphorylation | TDQSHLATAGSTSSH CCHHCCCCCCCCCCC | 37.60 | 27251275 | |
573 | Phosphorylation | SHLATAGSTSSHSLQ HCCCCCCCCCCCCEE | 23.74 | 27251275 | |
574 | Phosphorylation | HLATAGSTSSHSLQK CCCCCCCCCCCCEEE | 33.07 | 27251275 | |
575 | Phosphorylation | LATAGSTSSHSLQKY CCCCCCCCCCCEEEE | 27.96 | 27251275 | |
576 | Phosphorylation | ATAGSTSSHSLQKYY CCCCCCCCCCEEEEE | 19.72 | 27251275 | |
578 | Phosphorylation | AGSTSSHSLQKYYIT CCCCCCCCEEEEEEE | 34.15 | - | |
594 | Phosphorylation | EAEGFPATV------ CCCCCCCCC------ | 27.30 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
52 | Y | Phosphorylation | Kinase | ABL1 | P00519 | GPS |
52 | Y | Phosphorylation | Kinase | ABL-FAMILY | - | GPS |
102 | S | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
104 | S | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
104 | S | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
104 | S | Phosphorylation | Kinase | CDK3 | Q00526 | PSP |
104 | S | Phosphorylation | Kinase | MAPK3 | P27361 | GPS |
104 | S | Phosphorylation | Kinase | MTOR | P42345 | PSP |
104 | S | Phosphorylation | Kinase | CDK2 | P24941 | Uniprot |
104 | S | Phosphorylation | Kinase | CDK-FAMILY | - | GPS |
104 | S | Phosphorylation | Kinase | CDK_GROUP | - | PhosphoELM |
106 | S | Phosphorylation | Kinase | MTOR | P42345 | PSP |
106 | S | Phosphorylation | Kinase | MAPK3 | P27361 | GPS |
106 | S | Phosphorylation | Kinase | CDK-FAMILY | - | GPS |
106 | S | Phosphorylation | Kinase | CDK_GROUP | - | PhosphoELM |
106 | S | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
106 | S | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
106 | S | Phosphorylation | Kinase | CDK3 | Q00526 | PSP |
106 | S | Phosphorylation | Kinase | CDK2 | P24941 | Uniprot |
118 | S | Phosphorylation | Kinase | MAPK-FAMILY | - | GPS |
118 | S | Phosphorylation | Kinase | MAPK_GROUP | - | PhosphoELM |
118 | S | Phosphorylation | Kinase | CDK3 | Q00526 | PSP |
118 | S | Phosphorylation | Kinase | MAPK14 | Q16539 | GPS |
118 | S | Phosphorylation | Kinase | RSK-SUBFAMILY | - | GPS |
118 | S | Phosphorylation | Kinase | RSK_GROUP | - | PhosphoELM |
118 | S | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
118 | S | Phosphorylation | Kinase | CHUK | O15111 | GPS |
118 | S | Phosphorylation | Kinase | GSK3B | P49841 | PSP |
118 | S | Phosphorylation | Kinase | CDK7 | P50613 | PSP |
118 | S | Phosphorylation | Kinase | MAPK3 | P27361 | GPS |
118 | S | Phosphorylation | Kinase | DDR1 | Q08345 | GPS |
118 | S | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
167 | S | Phosphorylation | Kinase | CK2 | - | Uniprot |
167 | S | Phosphorylation | Kinase | AKT-FAMILY | - | GPS |
167 | S | Phosphorylation | Kinase | RSK-SUBFAMILY | - | GPS |
167 | S | Phosphorylation | Kinase | CK2-FAMILY | - | GPS |
167 | S | Phosphorylation | Kinase | AKT2 | P31751 | PSP |
167 | S | Phosphorylation | Kinase | AURKA | O14965 | GPS |
167 | S | Phosphorylation | Kinase | RSK_GROUP | - | PhosphoELM |
167 | S | Phosphorylation | Kinase | RPS6KB1 | P23443 | GPS |
167 | S | Phosphorylation | Kinase | RPS6KA3 | P51812 | GPS |
167 | S | Phosphorylation | Kinase | RPS6KA1 | Q15418 | GPS |
167 | S | Phosphorylation | Kinase | IKBKE | Q14164 | GPS |
167 | S | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
167 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
219 | Y | Phosphorylation | Kinase | ABL1 | P00519 | GPS |
219 | Y | Phosphorylation | Kinase | IGF1R | P08069 | PSP |
219 | Y | Phosphorylation | Kinase | ABL-FAMILY | - | GPS |
236 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
236 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
236 | S | Phosphorylation | Kinase | PKA_GROUP | - | PhosphoELM |
282 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
294 | S | Phosphorylation | Kinase | MAPK14 | Q16539 | GPS |
294 | S | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
305 | S | Phosphorylation | Kinase | TBK1 | Q9UHD2 | PSP |
305 | S | Phosphorylation | Kinase | AURKA | O14965 | GPS |
305 | S | Phosphorylation | Kinase | PAK4 | O96013 | PSP |
305 | S | Phosphorylation | Kinase | PAK1 | Q13153 | PSP |
305 | S | Phosphorylation | Kinase | PKA-FAMILY | - | GPS |
305 | S | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
305 | S | Phosphorylation | Kinase | PRKACA | P17612 | GPS |
311 | T | Phosphorylation | Kinase | MAPK-FAMILY | - | GPS |
311 | T | Phosphorylation | Kinase | MAPK14 | Q16539 | GPS |
311 | T | Phosphorylation | Kinase | MAPK_GROUP | - | PhosphoELM |
341 | S | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
537 | Y | Phosphorylation | Kinase | SRC64 | - | PhosphoELM |
537 | Y | Phosphorylation | Kinase | CDKL2 | Q92772 | GPS |
537 | Y | Phosphorylation | Kinase | LCK | P06239 | PSP |
537 | Y | Phosphorylation | Kinase | TYR-KINASES | - | Uniprot |
537 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
559 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
- | K | Ubiquitination | E3 ubiquitin ligase | SKP2 | Q13309 | PMID:23770852 |
- | K | Ubiquitination | E3 ubiquitin ligase | TRIM25 | Q14258 | PMID:16144914 |
- | K | Ubiquitination | E3 ubiquitin ligase | SPOP | O43791 | PMID:25766326 |
- | K | Ubiquitination | E3 ubiquitin ligase | BARD1 | Q99728 | PMID:22199232 |
- | K | Ubiquitination | E3 ubiquitin ligase | STUB1 | Q9UNE7 | PMID:12239347 |
- | K | Ubiquitination | E3 ubiquitin ligase | BRCA1 | P38398 | PMID:17392432 |
- | K | Ubiquitination | E3 ubiquitin ligase | RBX1 | P62877 | PMID:20130088 |
- | K | Ubiquitination | E3 ubiquitin ligase | AHR | P35869 | PMID:21397018 |
- | K | Ubiquitination | E3 ubiquitin ligase | UBE3A | Q05086 | PMID:23542176 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ESR1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
H00026 | Endometrial Cancer | |||||
OMIM Disease | ||||||
615363 | Estrogen resistance (ESTRR) | |||||
Kegg Drug | ||||||
D00067 | Estrone (JAN/USP/INN); Estrone (TN) | |||||
D00105 | Estradiol (JAN/USP/INN); Climara (TN); Divigel (TN); Estrace (TN); Estraderm (TN); Estrasorb (TN); E | |||||
D00185 | Estriol (JP16/USP); Estriel (TN) | |||||
D00312 | Estrone sodium sulfate; Sodium estrone sulfate | |||||
D00554 | Ethinylestradiol (JP16/INN); Ethinyl estradiol (USP); Estinyl (TN) | |||||
D00575 | Mestranol (JP16/USP/INN) | |||||
D00577 | Diethylstilbestrol (USP/INN); Stilbestrol (TN) | |||||
D00898 | Dienestrol (USP/INN); DV (TN) | |||||
D00946 | Fosfestrol (JAN/INN); Diethylstilbestrol diphosphate (USP); Stilphostrol (TN) | |||||
D00948 | Estropipate (USP); Piperazine estrone sulfate; Ogen (TN) | |||||
D00962 | Clomifene citrate (JP16); Clomiphene citrate (USP); Clomid (TN); Serophene (TN) | |||||
D00963 | Exemestane (JAN/USP/INN); Aromasin (TN) | |||||
D00964 | Letrozole (JAN/USP/INN); Femara (TN) | |||||
D00966 | Tamoxifen citrate (JP16/USP); Nolvadex (TN) | |||||
D00967 | Toremifene citrate (JAN/USAN); Fareston (TN) | |||||
D01161 | Fulvestrant (JAN/USAN/INN); Faslodex (TN) | |||||
D01265 | Epitiostanol (JAN/INN) | |||||
D01413 | Estradiol valerate (JAN/USP/INN); Deladumone (TN) | |||||
D01602 | Mepitiostane (JP16/INN); Thioderon (TN) | |||||
D01617 | Estradiol dipropionate (JAN); Ovahormon (TN) | |||||
D01639 | Tibolone (JAN/USAN/INN) | |||||
D01953 | Estradiol benzoate (JP16); Ovahormon (TN) | |||||
D01986 | Estriol tripropionate (JAN); Estriol (TN) | |||||
D01989 | Estriol diacetate benzoate (JAN); Estriol benzoate diacetate; Holin (TN) | |||||
D02217 | Raloxifene hydrochloride (JAN/USP); LY 156758; Evista (TN) | |||||
D02758 | Acolbifene hydrochloride (USAN) | |||||
D02993 | Arzoxifene hydrochloride (USAN) | |||||
D03062 | Bazedoxifene acetate (JAN/USAN); Viviant (TN) | |||||
D03911 | Droloxifene (USAN/INN) | |||||
D03912 | Droloxifene citrate (USAN) | |||||
D04041 | Equilin (USP) | |||||
D04061 | Estradiol acetate (USAN); Femring (TN) | |||||
D04063 | Estradiol cypionate (USP); Depo-estradiol (TN) | |||||
D04064 | Estradiol enanthate (USAN) | |||||
D04065 | Estradiol undecylate (USAN/INN); Delestrec (TN) | |||||
D04070 | Conjugated estrogens (JAN); Estrogens, conjugated (USP); Premarin (TN) | |||||
D04071 | Estrogens, esterified (USP); Amnestrogen (TN) | |||||
D04496 | Idoxifene (USAN/INN) | |||||
D04672 | Lasofoxifene tartrate (JAN/USAN) | |||||
D05106 | Nafoxidine hydrochloride (USAN) | |||||
D05192 | Nitromifene citrate (USAN) | |||||
D05987 | Synthetic conjugated estrogens, B (USAN); Enjuvia (TN) | |||||
D06245 | Trioxifene mesylate (USAN) | |||||
D06551 | Afimoxifene (USAN/INN); Tamogel (TN) | |||||
D07221 | Promestriene (INN); Colpotrophine (TN) | |||||
D07434 | Polyestradiol phosphate (INN); Estradurin (TN) | |||||
D07726 | Clomifene (INN); Clomiphene; Clomifene (TN) | |||||
D07826 | Hexestrol diphosphate sodium; Diethylstilbestrol diphosphate tetrasodium salt; Stilphostrol (TN) | |||||
D07918 | Estradiol hemihydrate; Estrasorb (TN); Vagifem (TN) | |||||
D07919 | Estradiol 17 beta-hemisuccinate; 17beta-Estradiol hemisuccinate; Eutocol (TN) | |||||
D07920 | Estriol succinate; Estriol 16alfa, 17beta-di (hydrogen succinate); Sinapause (TN) | |||||
D07921 | Estriol sodium succinate (BAN); Estriol 16alpha, 17beta-di (sodium succinate); Styptanon (TN) | |||||
D07928 | Ethinylestradiol propanesulfonate; Turisteron (TN) | |||||
D08301 | Ormeloxifene (INN); Centron (TN) | |||||
D08465 | Raloxifene (INN); Eviden (TN); Raxeto (TN) | |||||
D08559 | Tamoxifen (INN); Tamoxifen (TN); Tamoplex (TN) | |||||
D08620 | Toremifene (INN); Fareston (TN) | |||||
D08910 | Enclomiphene (USAN) | |||||
D08958 | Ospemifene (INN/USAN/BAN); Osphena (TN) | |||||
D09834 | Levormeloxifene fumarate (JAN) | |||||
D10008 | Fispemifene (USAN/INN) | |||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Methylation | |
Reference | PubMed |
"Regulation of estrogen rapid signaling through arginine methylationby PRMT1."; Le Romancer M., Treilleux I., Leconte N., Robin-Lespinasse Y.,Sentis S., Bouchekioua-Bouzaghou K., Goddard S., Gobert-Gosse S.,Corbo L.; Mol. Cell 31:212-221(2008). Cited for: METHYLATION AT ARG-260 BY PRMT1, MUTAGENESIS OF ARG-260, SUBCELLULARLOCATION, AND INTERACTION WITH PI3KR1/2; SRC AND PTK2/FAK1. | |
Phosphorylation | |
Reference | PubMed |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-7 AND SER-10, AND MASSSPECTROMETRY. | |
"Potentiation of human estrogen receptor alpha transcriptionalactivation through phosphorylation of serines 104 and 106 by thecyclin A-CDK2 complex."; Rogatsky I., Trowbridge J.M., Garabedian M.J.; J. Biol. Chem. 274:22296-22302(1999). Cited for: PHOSPHORYLATION AT SER-104 AND SER-106, AND MUTAGENESIS. |